ANABAnaptysBio, Inc.
What is the market doing?
No clear lean: nothing decisive, though a crowded short (+19% of shares).
Rangebound, no clear trend. Oversold (RSI 16). Price is −2% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ANAB is trading
AnaptysBio, Inc. is +231% over the past year while the S&P 500 is +18%: 213 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −2.5%
vs 200-day average · below trend, but not far
- RSI (14)
- 16
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 34%
Below its 52-week high
Details›
- Last close2026-10-09
- $45.97
- 1 monthS&P 500 +2.7%
- −17%
- 1 yearS&P 500 +18%
- +231%
- 5 yearsS&P 500 +88%
- +172%
- vs 50-day average$54.25
- −15%
- 52-week high
- $69.82
- 52-week low
- $13.97
- Annualised volatility
- 79%
| Year | Return |
|---|---|
| 2026 (year to date) | +42% |
| 2025 | +266% |
| 2024 | −38% |
| 2023 | −31% |
| 2022 | −11% |
| 2021 | +62% |
| 2020 | +32% |
| 2019 | −75% |
| 2018 | −37% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 5 of 9 | +3.8% |
| Feb | 10 | 8 of 10 | +8.8% |
| Mar | 10 | 4 of 10 | −5.5% |
| Apr | 10 | 5 of 10 | +10% |
| May | 10 | 4 of 10 | −4.1% |
| Jun | 10 | 6 of 10 | +1.3% |
| Jul | 10 | 5 of 10 | +1.3% |
| Aug | 10 | 6 of 10 | +2.4% |
| Sep | 10 | 5 of 10 | +4.2% |
| Oct | 10 | 6 of 10 | +17% |
| Nov | 9 | 3 of 9 | −4.4% |
| Dec | 9 | 6 of 9 | +5.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.